Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Ashleigh Herriott.
Newcastle Authors
Title
Year
Full text
Lucy Gentles
Bojidar Goranov
Elizabeth Matheson
Dr Ashleigh Herriott
Dr Angelika Kaufmann
et al.
Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
2019
Dr Ashleigh Herriott
Dr Miranda Patterson
Professor Nicola Curtin
Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline
BRCA1/2
mutations and selected sporadic cancers
2017
Fiona Middleton
Dr Miranda Patterson
Dr Claire Elstob
Dr Sarah Fordham
Dr Ashleigh Herriott
et al.
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition
2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Patterson
et al.
PARP1 expression, activity and
ex vivo
sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia
2015
Dr Jun-yong Huang
Dr Ashleigh Herriott
A deficiency of the Cdk1 phosphorylation of fizzy increases the binding affinity to cyclin B and reduces the affinities to BubR1 and Mad2 in Drosophila melanogaster
2013
Dr Ashleigh Herriott
Dr Michele Sweeney
Emeritus Professor Michael Whitaker
Professor Michael Taggart
Dr Jun-yong Huang
et al.
Kinetochore localized Mad2 and Cdc20 is itself insufficient for triggering the mitotic checkpoint when Mps1 is low in
Drosophila melanogaster
neuroblasts
2012